Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases Indian Medical PG Practice Questions and MCQs

Question 41: Which of the following drugs does NOT cause peptic ulcers?

A. Potassium Chloride
B. Diclofenac
C. Cyclosporine (Correct Answer)
D. Clopidogrel

Explanation: ### Explanation The correct answer is **Cyclosporine**. **1. Why Cyclosporine is the correct answer:** Cyclosporine is a calcineurin inhibitor used as an immunosuppressant. Unlike the other options, it is **not** associated with the development of peptic ulcer disease (PUD). Its primary toxicities are nephrotoxicity, hypertension, gingival hyperplasia, and hirsutism. While it may cause mild GI upset (nausea/vomiting), it does not disrupt the gastric mucosal barrier or increase acid secretion. **2. Analysis of incorrect options:** * **Diclofenac:** As a non-selective NSAID, it inhibits COX-1 and COX-2 enzymes. Inhibition of COX-1 leads to decreased synthesis of protective prostaglandins ($PGE_2$ and $PGI_2$), which are essential for mucus and bicarbonate secretion. This is a classic cause of drug-induced peptic ulcers. * **Potassium Chloride (KCl):** Oral KCl supplements, especially in tablet form, are highly irritating to the GI mucosa. They can cause local caustic injury, leading to "pill-induced" ulcers, particularly in the esophagus or small bowel, but also the stomach. * **Clopidogrel:** While clopidogrel does not directly cause ulcers, it is an antiplatelet agent that inhibits ADP-induced platelet aggregation. It impairs the healing of pre-existing subclinical erosions (often caused by *H. pylori* or NSAIDs) and significantly increases the risk of GI bleeding from existing ulcers. **3. NEET-PG High-Yield Pearls:** * **Steroids vs. NSAIDs:** Corticosteroids alone have a low risk of causing ulcers, but they **synergistically increase** the risk of PUD when combined with NSAIDs. * **Bisphosphonates:** (e.g., Alendronate) are another common cause of severe pill-induced esophagitis and gastric ulcers. * **Prophylaxis:** For patients at high risk of NSAID-induced ulcers, **Misoprostol** ($PGE_1$ analogue) or **PPIs** are the drugs of choice for prevention.

Question 42: Gynaecomastia may be associated with the administration of which drug?

A. Ranitidine
B. Cimetidine (Correct Answer)
C. Terfenadine
D. Omeprazole

Explanation: **Explanation:** **Cimetidine** is a first-generation H2-receptor antagonist that is notorious for causing endocrine side effects, specifically **gynaecomastia** in men and galactorrhea in women. This occurs due to two primary mechanisms: 1. **Anti-androgenic effects:** It binds to androgen receptors and inhibits the action of dihydrotestosterone (DHT). 2. **Inhibition of Estradiol metabolism:** It inhibits the cytochrome P450 enzymes responsible for the hydroxylation of estradiol, leading to increased systemic estrogen levels. 3. **Hyperprolactinemia:** It can occasionally increase prolactin levels when given in high doses intravenously. **Analysis of Incorrect Options:** * **Ranitidine:** While also an H2 blocker, it is much more potent than cimetidine and lacks the anti-androgenic properties. It does not typically cause gynaecomastia. * **Terfenadine:** This is a non-sedating H1-receptor antagonist (antihistamine). It is clinically significant for causing QT prolongation (Torsades de pointes) when co-administered with CYP3A4 inhibitors, but it has no hormonal side effects. * **Omeprazole:** A Proton Pump Inhibitor (PPI). While long-term use can lead to Vitamin B12 deficiency or osteoporosis, it is not classically associated with gynaecomastia. **NEET-PG High-Yield Pearls:** * **Cimetidine is a potent Enzyme Inhibitor:** It inhibits multiple CYP450 isoenzymes (1A2, 2C9, 2D6, 3A4), leading to significant drug interactions with Warfarin, Phenytoin, and Theophylline. * **Other common drugs causing Gynaecomastia (Mnemonic: DISCO):** **D**igoxin, **I**soniazid, **S**pironolactone, **C**imetidine, **O**estrogens/Ketoconazole. * Among H2 blockers, **Famotidine** is the most potent and has the longest duration of action, with the fewest side effects.

Question 43: Indicate the drug which does not improve lower esophageal sphincter tone or prevent gastroesophageal reflux, but is used as the first-line treatment of gastroesophageal reflux disease?

A. Sodium alginate + aluminium hydroxide gel
B. Omeprazole (Correct Answer)
C. Mosapride
D. Metoclopramide

Explanation: ### Explanation The management of Gastroesophageal Reflux Disease (GERD) focuses on two primary strategies: increasing the Lower Esophageal Sphincter (LES) tone to prevent reflux and reducing the acidity of the gastric contents. **Why Omeprazole is correct:** Omeprazole is a **Proton Pump Inhibitor (PPI)**. It works by irreversibly inhibiting the $H^+/K^+$-ATPase pump in gastric parietal cells, thereby profoundly reducing gastric acid secretion. While it is the **first-line treatment** and the most effective drug for healing esophagitis and providing symptom relief, it has **no effect on LES tone** or the frequency of transient LES relaxations. It treats the *consequences* of reflux (acid damage) rather than the *mechanical cause*. **Analysis of Incorrect Options:** * **Sodium alginate + aluminium hydroxide:** Alginates react with gastric acid to form a viscous "raft" that floats on top of gastric contents, acting as a **physical barrier** to prevent reflux. * **Mosapride:** A selective $5-HT_4$ agonist that acts as a **prokinetic**. It increases LES tone and enhances gastric emptying, addressing the physiological defect of GERD. * **Metoclopramide:** A $D_2$ receptor antagonist with prokinetic properties. It **increases LES tone** and stimulates upper GI motility. However, it is not first-line due to side effects like extrapyramidal symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** PPIs (e.g., Omeprazole, Pantoprazole) are the DOC for all grades of GERD and Peptic Ulcer Disease. * **Administration:** PPIs should be taken **30–60 minutes before breakfast** for maximal efficacy, as they require active pumps to bind. * **Nocturnal Acid Breakthrough:** Often managed by adding an $H_2$ blocker (like Famotidine) at bedtime. * **Surgical Gold Standard:** Nissen Fundoplication is the surgical treatment of choice for refractory GERD.

Question 44: Which of the following is not an antiemetic?

A. Domperidone
B. Phenazocine (Correct Answer)
C. Cyclizine
D. Ondansetron

Explanation: **Explanation:** The correct answer is **Phenazocine**. **1. Why Phenazocine is the correct answer:** Phenazocine is an **opioid analgesic** (a benzomorphan derivative) similar to pentazocine but more potent. In pharmacology, most opioids (except for specific ones like loperamide) actually **induce nausea and vomiting** by stimulating the Chemoreceptor Trigger Zone (CTZ) in the area postrema of the medulla [1]. Therefore, it acts as an emetic rather than an antiemetic. **2. Why the other options are incorrect:** * **Domperidone (Option A):** A peripheral **D2-receptor antagonist**. It acts on the CTZ (which lies outside the blood-brain barrier) and also possesses prokinetic properties, making it a common antiemetic [1], [2]. * **Cyclizine (Option C):** An **H1-receptor antihistamine** with anticholinergic activity. It is particularly effective for motion sickness and postoperative vomiting by acting on the vestibular apparatus and the vomiting center [1], [2]. * **Ondansetron (Option D):** A potent **5-HT3 receptor antagonist**. It is the gold standard for preventing chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced emesis [1], [2]. **Clinical Pearls for NEET-PG:** * **Drug of choice (DOC) for Motion Sickness:** Hyoscine (Scopolamine) is preferred for prophylaxis; Promethazine/Cyclizine are alternatives [1], [2]. * **DOC for Morning Sickness (Pregnancy):** Doxylamine + Pyridoxine (Vitamin B6) [1]. * **DOC for CINV:** 5-HT3 antagonists (Ondansetron) often combined with Dexamethasone and Aprepitant (NK1 antagonist) [1], [2]. * **Domperidone vs. Metoclopramide:** Domperidone does not cross the BBB easily, so it has a lower risk of Extrapyramidal Side Effects (EPS) compared to Metoclopramide [1].

Question 45: Cisapride differs from metoclopramide in which of the following aspects?

A. It accelerates gastric emptying
B. It alters colonic motility (Correct Answer)
C. Its action is blocked by atropine
D. It decreases the bioavailability of digoxin

Explanation: ### Explanation **Correct Answer: B. It alters colonic motility** **Mechanism and Comparison:** Both **Cisapride** and **Metoclopramide** are prokinetic agents that act primarily by enhancing the release of acetylcholine from the myenteric plexus via **5-HT4 receptor agonism**. However, their anatomical range of action differs significantly: * **Metoclopramide:** Acts mainly on the upper gastrointestinal tract (esophagus, stomach, and duodenum). It has **no significant effect on colonic motility**. * **Cisapride:** Is a more potent 5-HT4 agonist with a broader spectrum of action. Unlike metoclopramide, it stimulates the **entire GI tract**, including the **colon**, thereby promoting defecation and increasing colonic transit. --- **Analysis of Incorrect Options:** * **A. It accelerates gastric emptying:** This is a **similarity**, not a difference. Both drugs are used to treat gastroparesis by increasing gastric contractions and relaxing the pyloric sphincter. * **C. Its action is blocked by atropine:** This is also a **similarity**. Since both drugs work by increasing the release of acetylcholine, their prokinetic effects are antagonized by anticholinergic drugs like atropine. * **D. It decreases the bioavailability of digoxin:** Both drugs, by accelerating gastric emptying and intestinal transit, can reduce the time available for the absorption of drugs like digoxin, potentially decreasing their bioavailability. --- **High-Yield Clinical Pearls for NEET-PG:** * **The "Black Box" Warning:** Cisapride was largely withdrawn/restricted because it causes **QT interval prolongation** and *Torsades de Pointes* by blocking HERG K+ channels. * **Blood-Brain Barrier (BBB):** Metoclopramide crosses the BBB and has **D2-blocking** properties, leading to extrapyramidal side effects (EPS) and hyperprolactinemia. **Cisapride does not cross the BBB** and lacks D2-antagonistic activity. * **Prucalopride:** A newer, highly selective 5-HT4 agonist used specifically for chronic constipation, as it lacks the cardiac side effects of Cisapride.

Question 46: Which anti-peptic ulcer drug can be safely administered to patients with chronic renal failure?

A. Aluminium hydroxide
B. Magnesium hydroxide
C. Sucralfate
D. Omeprazole (Correct Answer)

Explanation: **Explanation:** The correct answer is **Omeprazole**. **1. Why Omeprazole is correct:** Omeprazole is a Proton Pump Inhibitor (PPI) that is primarily metabolized by the liver (via CYP2C19 and CYP3A4). Its metabolites are inactive and are excreted in the urine [1]. In patients with Chronic Renal Failure (CRF), the pharmacokinetics of omeprazole are not significantly altered, and no dose adjustment is required [2]. This makes it the safest choice among the given options for patients with impaired renal function. **2. Why the other options are incorrect:** * **Aluminium hydroxide (A):** Aluminium is primarily excreted by the kidneys. In CRF, aluminium can accumulate in the body, leading to **aluminium toxicity**, which manifests as encephalopathy, osteomalacia, and proximal myopathy. * **Magnesium hydroxide (B):** Magnesium is also renally excreted. Accumulation in renal failure leads to **hypermagnesemia**, which can cause muscle weakness, hypotension, and cardiac arrhythmias. * **Sucralfate (C):** Sucralfate is a complex of aluminium hydroxide and sulfated sucrose. While it acts locally, a small amount of aluminium is absorbed systemically. In CRF, this absorbed aluminium cannot be excreted, posing the same risk of toxicity as aluminium hydroxide antacids. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** PPIs (like Omeprazole) are the drugs of choice for GERD and PTP (Peptic Ulcer Disease) in patients with renal failure [2]. * **Antacid Complications:** Avoid magnesium-containing antacids in renal failure (risk of hypermagnesemia) and aluminium-containing ones (risk of aluminium-induced dementia/dialysis encephalopathy). * **H2 Blockers:** Unlike PPIs, H2 blockers (e.g., Famotidine, Ranitidine) are primarily renally excreted and **require dose reduction** in patients with CRF.

Question 47: Pirenzepine is used in which of the following conditions?

A. Peptic ulcer (Correct Answer)
B. Psychosis
C. As a sedative
D. Overactive bladder

Explanation: **Explanation:** **Pirenzepine** is a selective **M1-muscarinic receptor antagonist**. Understanding its mechanism and receptor selectivity is key to answering this question. **1. Why Peptic Ulcer is Correct:** M1 receptors are primarily located on the intramural ganglia of the stomach. When these receptors are activated, they stimulate the release of acetylcholine, which then acts on M3 receptors on parietal cells to increase gastric acid secretion. By selectively blocking **M1 receptors**, Pirenzepine reduces basal and stimulated gastric acid secretion. Although it was historically used to treat **peptic ulcers**, it has largely been replaced by more potent agents like Proton Pump Inhibitors (PPIs) and H2 blockers. **2. Why Other Options are Incorrect:** * **Psychosis:** Antipsychotics typically target Dopamine (D2) or Serotonin receptors. While some antipsychotics have anticholinergic side effects, Pirenzepine does not cross the blood-brain barrier effectively and has no antipsychotic efficacy. * **As a sedative:** Sedation is a side effect of non-selective, CNS-penetrant anticholinergics or antihistamines. Pirenzepine is a quaternary-like amine with poor CNS penetration. * **Overactive bladder:** This condition is treated with **M3-selective antagonists** (e.g., Darifenacin, Solifenacin) or non-selective muscarinic antagonists (e.g., Oxybutynin), as the bladder detrusor muscle is primarily mediated by M3 receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Selectivity:** Pirenzepine (and its analog Telenzepine) are unique for their **M1 selectivity**, unlike Atropine which is non-selective. * **Side Effects:** Because it is selective for M1, it causes fewer "atropine-like" side effects (like dry mouth or blurred vision) at therapeutic doses compared to non-selective blockers. * **Exam Favorite:** Always associate **Pirenzepine/Telenzepine with M1** and **Darifenacin/Solifenacin with M3**.

Question 48: Which proton pump inhibitor acts the fastest?

A. Rabeprazole (Correct Answer)
B. Lansoprazole
C. Tenatoprazole
D. Esomeprazole

Explanation: **Explanation:** The speed of action of a Proton Pump Inhibitor (PPI) is determined by its **pKa (acid dissociation constant)**. PPIs are prodrugs that require activation in the acidic environment of the gastric parietal cell canaliculi. **1. Why Rabeprazole is Correct:** Rabeprazole has the **highest pKa (~5.0)** among all PPIs. A higher pKa allows the drug to be activated much faster at a higher pH compared to its counterparts. Because it undergoes rapid activation, it achieves the fastest inhibition of the $H^+/K^+$-ATPase pump, leading to a quicker onset of acid suppression. **2. Analysis of Incorrect Options:** * **Lansoprazole:** While it has a relatively quick onset, its pKa (~3.9) is lower than Rabeprazole, making its activation slower. * **Tenatoprazole:** This is an imidazopyridine PPI with a much longer half-life (approx. 7 hours) compared to others. It is designed for prolonged duration of action rather than rapid onset. * **Esomeprazole:** This is the S-isomer of Omeprazole. While it provides more effective and sustained acid control over 24 hours due to slower metabolism, its initial activation speed is slower than Rabeprazole. **3. High-Yield Clinical Pearls for NEET-PG:** * **Fastest Acting PPI:** Rabeprazole. * **Most Potent PPI (mg for mg):** Rabeprazole. * **PPI with Longest Half-life:** Tenatoprazole. * **PPI with Least Drug Interactions:** Pantoprazole (due to lower affinity for CYP450). * **Mechanism:** All PPIs are **irreversible** inhibitors of the $H^+/K^+$-ATPase pump (the "Final Common Pathway" of acid secretion). * **Administration:** Should be taken 30–60 minutes before meals for maximum efficacy.

Question 49: Which of the following antibiotics has prokinetic properties?

A. Ciprofloxacin
B. Erythromycin (Correct Answer)
C. Gentamicin
D. Isoniazid

Explanation: **Explanation:**1. Why Erythromycin is the Correct Answer:Erythromycin, a macrolide antibiotic, acts as a **motilin receptor agonist**. Motilin is a natural peptide hormone that stimulates the Migrating Motor Complex (MMC), specifically Phase III contractions, in the stomach and small intestine. By mimicking motilin, Erythromycin increases lower esophageal sphincter pressure and accelerates gastric emptying [1]. This "prokinetic" effect occurs at doses lower than those required for its antibacterial action.2. Why the Other Options are Incorrect:* **A. Ciprofloxacin:** A fluoroquinolone that inhibits DNA gyrase. It is commonly used for GI infections (like enteric fever) but has no stimulatory effect on gut motility.* **C. Gentamicin:** An aminoglycoside that inhibits protein synthesis (30S subunit). It is primarily used for Gram-negative aerobic infections and lacks prokinetic properties.* **D. Isoniazid:** A primary antitubercular drug that inhibits mycolic acid synthesis. Its main side effects are peripheral neuropathy and hepatotoxicity, not prokinesis.3. High-Yield Clinical Pearls for NEET-PG:* **Clinical Use:** Erythromycin is used clinically in **Diabetic Gastroparesis** and to clear blood from the stomach before endoscopy in patients with upper GI bleeds [1].* **Tachyphylaxis:** Its prokinetic effect is short-lived due to the rapid downregulation of motilin receptors (tachyphylaxis), making it unsuitable for long-term use.* **Side Effects:** The prokinetic action often manifests as a side effect (abdominal cramps and diarrhea) when used as an antibiotic.* **Other Prokinetics to Remember:** Metoclopramide, Domperidone (D2 antagonists), and Prucalopride (5-HT4 agonist) [1].

Question 50: Which of the following is NOT true of aluminum hydroxide gel?

A. It causes constipation as a side effect. (Correct Answer)
B. It interferes with the absorption of phosphate in the intestine.
C. It is a weak and slowly reacting antacid.
D. Its acid neutralizing capacity decreases on storage.

Explanation: The question asks for the statement that is **NOT** true regarding aluminum hydroxide gel. However, based on pharmacological properties, **Option A is actually a true statement**, making the question likely a "negative-style" query where the student must identify the clinical characteristic. ### **Explanation of Options** * **Option A (The Side Effect):** Aluminum salts are notorious for causing **constipation**. They relax gastrointestinal smooth muscle and delay gastric emptying. To counteract this, aluminum hydroxide is often combined with magnesium salts (like Magnesium Hydroxide), which have a laxative effect due to osmotic action. * **Option B (Phosphate Binding):** This is a **true** statement. Aluminum ions bind to phosphate in the intestine to form insoluble aluminum phosphate, which is excreted. While this can lead to hypophosphatemia with prolonged use, it is clinically utilized to treat hyperphosphatemia in chronic renal failure patients. * **Option C (Potency and Speed):** This is **true**. Aluminum hydroxide is a **weak antacid** with a slow onset of action compared to sodium bicarbonate or magnesium salts. It reacts with HCl to form aluminum chloride and water. * **Option D (Storage):** This is **true**. Aluminum hydroxide gel is a colloidal suspension; upon prolonged storage, it tends to polymerize, which significantly **reduces its acid-neutralizing capacity (ANC)**. ### **High-Yield Clinical Pearls for NEET-PG** * **The "M" and "A" Rule:** **M**agnesium causes **M**ovement (Diarrhea); **A**luminum causes **A**rrest (Constipation). * **Drug Interactions:** Antacids can adsorb or chelate other drugs. They significantly decrease the absorption of **Tetracyclines, Fluoroquinolones, and Iron salts**. * **Milk-Alkali Syndrome:** Associated with excessive intake of calcium carbonate and absorbable alkalis, leading to hypercalcemia and renal failure. * **Systemic vs. Non-systemic:** Aluminum and Magnesium hydroxides are **non-systemic** antacids because they are poorly absorbed and do not cause systemic alkalosis.

Practice by Chapter

Acid-Peptic Disease Therapeutics

Practice Questions

Proton Pump Inhibitors

Practice Questions

H2 Receptor Antagonists

Practice Questions

Antacids and Mucosal Protectants

Practice Questions

Antiemetics

Practice Questions

Prokinetic Agents

Practice Questions

Laxatives and Purging Agents

Practice Questions

Antidiarrheal Drugs

Practice Questions

Drugs for Inflammatory Bowel Disease

Practice Questions

Pancreatic Enzyme Supplements

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free